Breems et al developed a prognostic index for a patient with acute myelogenous leukemia having a first relapse. This can help identify patients who may require more aggressive management. The authors are from the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and the Swiss Group for Clinical Cancer Research Collaborative Group (SAKK).